Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
15 August 2022 |
Main ID: |
NCT02477644 |
Date of registration:
|
18/06/2015 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
Platine, Avastin and OLAparib in 1st Line
PAOLA-1 |
Scientific title:
|
Randomized, Double-Blind, Phase III Trial Olaparib vs. Placebo Patients With Advanced FIGO Stage IIIB-IV High Grade Serious or Endometrioid Ovarian, Fallopian Tube, or Peritoneal Cancer Treated Standard First-Line Treatment |
Date of first enrolment:
|
May 6, 2015 |
Target sample size:
|
806 |
Recruitment status: |
Completed |
URL:
|
https://clinicaltrials.gov/show/NCT02477644 |
Study type:
|
Interventional |
Study design:
|
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Triple (Participant, Care Provider, Investigator).
|
Phase:
|
Phase 3
|
|
Countries of recruitment
|
Austria
|
Belgium
|
Denmark
|
Finland
|
France
|
Germany
|
Italy
|
Japan
|
Monaco
|
Spain
|
Sweden
| | | | | |
Contacts
|
Name:
|
Isabelle RAY COQUARD, MD, PhD |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Centre Leon Berard |
| | |
Key inclusion & exclusion criteria
|
Health Condition(s) or Problem(s) studied
|
Source(s) of Monetary Support
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|